Area of research
Oncology · Immunology
Research interest
Research interests include Cancer research, Chimeric antigen receptor, CD28, Lung cancer, T cell, and Mesothelin.
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy
CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression